Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SHL.DE
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio 17.84 1.31 1.12
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1605.27 14.43 -0.85
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 4.24 16.66 15.98
Cash 33.20 2.36 1.77
Capex -25.44 -0.15 -0.12
Free Cash Flow -69.40 0.07 0.21
Revenue 4.74 4.86 4.64
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -2.78 0.37 0.38
Operating Margin -5.35 0.12 0.13
ROA -2.89 < 0.005 < 0.005
ROE -5.41 0.02 0.02
ROIC -46.80 0.01 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SHL.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SHL.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SHL.DE is permitted for members.